Loading…
Lobbying Spend
—
Filings
35
Firms Hired
1
Active Period
2018–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
2026 · first_quarter · Firm: MGD STRATEGIES LLC
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R. 842)
Client expense: — · Firm income: —
Matched citations: H.R. 842
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
2026 · first_quarter · Firm: MGD STRATEGIES LLC
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R. 842)
Client expense: — · Firm income: —
Matched citations: H.R. 842
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
2025 · fourth_quarter · Firm: MGD STRATEGIES LLC
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R. 842)
Client expense: — · Firm income: —
Matched citations: H.R. 842
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
2025 · third_quarter · Firm: MGD STRATEGIES LLC
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R. 842)
Client expense: — · Firm income: —
Matched citations: H.R. 842
Advocating for the Clinical TREATMENT Act (H.R. 913)
Client expense: — · Firm income: —
Matched citations: H.R. 913
Cancer Drug Parity Act of 2019
2020 · third_quarter · Firm: MGD STRATEGIES LLC
Advocating for the Clinical TREATMENT Act (H.R. 913) Advocating for the following as part of the next COVID package: Cancer Drug Parity Act (H.R. 1730/S. 741) Coverage for 90 day supply of cancer medications Creating a Special Enrollment Period for Healthcare.gov
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1730
Advocating for the Clinical TREATMENT Act (H.R. 913) Advocating for the following as part of the next COVID package: Cancer Drug Parity Act (H.R. 1730/S. 741) Coverage for 90 day supply of cancer medications Creating a Special Enrollment Period for Healthcare.gov
Client expense: — · Firm income: $20,000
Matched citations: H.R. 913
Advocating for the Clinical TREATMENT Act (H.R. 913) Advocating for the following as part of the next COVID package: Cancer Drug Parity Act (H.R. 1730/S. 741) Coverage for 90 day supply of cancer medications Creating a Special Enrollment Period for Healthcare.gov
Client expense: — · Firm income: $20,000
Matched citations: S. 741
Cancer Drug Parity Act of 2019
2020 · second_quarter · Firm: MGD STRATEGIES LLC
Advocating for the Clinical TREATMENT Act (H.R. 913) Advocating for the following as part of the next COVID package: Cancer Drug Parity Act (H.R. 1730/S. 741) Coverage for 90 day supply of cancer medications Creating a Special Enrollment Period for Healthcare.gov
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1730
Advocating for the Clinical TREATMENT Act (H.R. 913) Advocating for the following as part of the next COVID package: Cancer Drug Parity Act (H.R. 1730/S. 741) Coverage for 90 day supply of cancer medications Creating a Special Enrollment Period for Healthcare.gov
Client expense: — · Firm income: $20,000
Matched citations: H.R. 913
Advocating for the Clinical TREATMENT Act (H.R. 913) Advocating for the following as part of the next COVID package: Cancer Drug Parity Act (H.R. 1730/S. 741) Coverage for 90 day supply of cancer medications Creating a Special Enrollment Period for Healthcare.gov
Client expense: — · Firm income: $20,000
Matched citations: S. 741
Advocating for the Clinical TREATMENT Act (H.R. 913)
Client expense: — · Firm income: $20,000
Matched citations: H.R. 913
Source: Senate LDA